Influential factors in the adherence and abandonment of preventive therapy for latent tuberculosis infection in patients with HIV

被引：0
|
作者：
Bedoya Serna, Beatriz Eugenia [1 ]
机构：
[1] Corp Invest Biol, Medellin, Colombia
来源：
ARCHIVOS DE MEDICINA | 2019年 / 19卷 / 01期
关键词：
HIV; latent tuberculosis; chemoprevention; FAILURE; PREDICTORS; ADULTS; TRIAL;
D O I：
10.30554/archmed.19.1.2791.2019
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Objective: to describe the factors that influence the lack of adherence to the treatment of the latent tuberculosis infection. Materials and methods: retrospective and descriptive study in people living with the human immunodeficiency virus treated in a health institution of Medellin, Colombia. Results: 45% of patients presented adherence problems such as interruptions less than 30 days or loss of follow-up, the statistical significance (p < 0.05) was presented in the variables of adverse effects and adherence to antiretroviral treatment. Conclusion: adverse effects to treatment and adherence to antiretroviral therapy are associated with problems of adherence to preventive treatment of latent tuberculosis infection.
引用
收藏
页数：12
相关论文
共 50 条
  • [1] Factors Associated with Absence of Active Pulmonary Tuberculosis in HIV Patients with Latent Tuberculosis, Beyond Isoniazid Preventive Therapy
    Yuniati, Shinta Karina
    Kusmiati, Tutik
    INTERNATIONAL JOURNAL OF MYCOBACTERIOLOGY, 2024, 13 (03) : 293 - 298
  • [2] Latent Tuberculosis and HIV Infection
    Bares, Sara H.
    Swindells, Susan
    CURRENT INFECTIOUS DISEASE REPORTS, 2020, 22 (07)
  • [3] Factors That Influence Treatment Completion for Latent Tuberculosis Infection
    Eastment, McKenna C.
    McClintock, Adelaide H.
    McKinney, Christy M.
    Narita, Masahiro
    Molnar, Alexandra
    JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2017, 30 (04) : 520 - 527
  • [4] Relation Risk Factors with Latent Tuberculosis Infection (LTBI) in HIV Patients
    Reviono
    Harsini
    Irwandi, D.
    ADVANCED SCIENCE LETTERS, 2018, 24 (09) : 6852 - 6855
  • [5] Preventive therapy for latent tuberculosis infection-the promise and the challenges
    Fox, G. J.
    Dobler, C. C.
    Marais, B. J.
    Denholm, J. T.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2017, 56 : 68 - 76
  • [6] Acceptability and adherence to Isoniazid preventive therapy in HIV-infected patients clinically screened for latent tuberculosis in Dar es Salaam, Tanzania
    Shayo, Grace A.
    Moshiro, Candida
    Aboud, Said
    Bakari, Muhammad
    Mugusi, Ferdinand M.
    BMC INFECTIOUS DISEASES, 2015, 15
  • [7] Latent Tuberculosis and HIV Infection
    Sara H. Bares
    Susan Swindells
    Current Infectious Disease Reports, 2020, 22
  • [8] Twice weekly tuberculosis preventive therapy in HIV infection in Zambia
    Mwinga, A
    Hosp, M
    Godfrey-Faussett, P
    Quigley, M
    Mwaba, P
    Mugala, BN
    Nyirenda, O
    Luo, N
    Pobee, J
    Elliott, AM
    McAdam, KPWJ
    Porter, JDH
    AIDS, 1998, 12 (18) : 2447 - 2457
  • [9] Active tuberculosis and Mycobacterium tuberculosis latent infection in patients with HIV/AIDS
    Gutierrez, E. B.
    Gomes, V.
    Picone, C. M.
    Suga, H.
    Atomiya, A. N.
    HIV MEDICINE, 2009, 10 (09) : 564 - 572
  • [10] Preventive therapy for HIV-associated tuberculosis
    Durovni, Betina
    Cavalcante, Solange
    CURRENT OPINION IN HIV AND AIDS, 2018, 13 (06) : 507 - 511
12345